Last updated: December 9, 2020
Sponsor: Centre Hospitalier de Cayenne
Overall Status: Active - Recruiting
Phase
N/A
Condition
Fever
Treatment
N/AClinical Study ID
NCT04422782
PrediDengue
Ages > 5 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age> = 5 years
- Patient / parent consent
- Exclude other pathology with capillary circulation problem (septic shock, anaphylaxis)All suspected dengue fever requiring hospitalization will be included, final inclusionbeing after biological confirmation (AgNS1, RT-PCR, serology).
Exclusion
Exclusion Criteria:
- Age <5 years
- Refusal to participate
- Unsigned consent
- Coinfection by another agent
- Patient under guardianship or curatorship.
Study Design
Total Participants: 342
Study Start date:
May 14, 2020
Estimated Completion Date:
May 14, 2023
Study Description
Connect with a study center
General Hospital of Cayenne
Cayenne, French Guiana 97306
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.